Jurgi Camblong Sells 8,500 Shares of SOPHiA GENETICS (NASDAQ:SOPH) Stock

SOPHiA GENETICS SA (NASDAQ:SOPH - Get Free Report) CEO Jurgi Camblong sold 8,500 shares of the company's stock in a transaction that occurred on Wednesday, June 10th. The shares were sold at an average price of $5.24, for a total transaction of $44,540.00. Following the completion of the sale, the chief executive officer owned 3,620,995 shares of the company's stock, valued at approximately $18,974,013.80. This trade represents a 0.23% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jurgi Camblong also recently made the following trade(s):

• On Monday, April 20th, Jurgi Camblong sold 4,486 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $5.21, for a total transaction of $23,372.06.
• On Wednesday, April 15th, Jurgi Camblong sold 17,473 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $5.00, for a total transaction of $87,365.00.
• On Tuesday, April 14th, Jurgi Camblong sold 43,129 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.96, for a total transaction of $213,919.84.
• On Monday, April 13th, Jurgi Camblong sold 4,399 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.76, for a total transaction of $20,939.24.
• On Friday, April 10th, Jurgi Camblong sold 12,232 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.72, for a total transaction of $57,735.04.
• On Thursday, April 9th, Jurgi Camblong sold 1,950 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.74, for a total transaction of $9,243.00.
• On Wednesday, April 8th, Jurgi Camblong sold 2,800 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.84, for a total transaction of $13,552.00.
• On Tuesday, April 7th, Jurgi Camblong sold 2,500 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.86, for a total transaction of $12,150.00.
• On Monday, April 6th, Jurgi Camblong sold 2,600 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.85, for a total transaction of $12,610.00.
• On Thursday, March 19th, Jurgi Camblong sold 4,486 shares of SOPHiA GENETICS stock. The shares were sold at an average price of $4.77, for a total transaction of $21,398.22.

SOPHiA GENETICS Stock Down 0.4%

---

---

Shares of NASDAQ:SOPH opened at $5.20 on Friday. SOPHiA GENETICS SA has a 52 week low of $2.59 and a 52 week high of $5.70. The company has a debt-to-equity ratio of 1.05, a quick ratio of 1.90 and a current ratio of 2.06. The company has a market cap of $356.13 million, a PE ratio of -10.00 and a beta of 0.98. The firm has a 50 day simple moving average of $4.98 and a 200 day simple moving average of $4.89.

SOPHiA GENETICS (NASDAQ:SOPH - Get Free Report) last released its earnings results on Tuesday, May 5th. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.23) by ($0.04). SOPHiA GENETICS had a negative return on equity of 62.74% and a negative net margin of 44.48%.The company had revenue of $21.69 million during the quarter, compared to analysts' expectations of $20.40 million.

Institutional Inflows and Outflows

Several hedge funds have recently modified their holdings of the business. Silverberg Bernstein Capital Management LLC increased its stake in shares of SOPHiA GENETICS by 8.7% during the 1st quarter. Silverberg Bernstein Capital Management LLC now owns 51,970 shares of the company's stock worth $257,000 after purchasing an additional 4,155 shares during the last quarter. Green Alpha Advisors LLC increased its stake in shares of SOPHiA GENETICS by 10.8% during the 4th quarter. Green Alpha Advisors LLC now owns 45,660 shares of the company's stock worth $213,000 after purchasing an additional 4,444 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of SOPHiA GENETICS by 24.7% during the 3rd quarter. Dimensional Fund Advisors LP now owns 31,332 shares of the company's stock worth $148,000 after purchasing an additional 6,205 shares during the last quarter. Principal Financial Group Inc. increased its stake in shares of SOPHiA GENETICS by 0.7% during the 1st quarter. Principal Financial Group Inc. now owns 1,409,242 shares of the company's stock worth $6,976,000 after purchasing an additional 9,800 shares during the last quarter. Finally, First Dallas Securities Inc. acquired a new position in shares of SOPHiA GENETICS during the 1st quarter worth $50,000. Institutional investors and hedge funds own 31.59% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have issued reports on SOPH. Weiss Ratings reiterated a "sell (d-)" rating on shares of SOPHiA GENETICS in a research report on Tuesday, April 21st. BTIG Research reiterated a "buy" rating and issued a $8.00 target price on shares of SOPHiA GENETICS in a research report on Wednesday, May 6th. Two analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $7.50.

Get Our Latest Stock Analysis on SOPH

About SOPHiA GENETICS

(Get Free Report)

SOPHiA GENETICS SA is a data-driven medicine company founded in 2011 and headquartered in La Tène, Switzerland. The firm develops and operates a cloud-native software platform designed to standardize and analyze complex genomic and radiomic data. Its core offering, the SOPHiA DDM™ platform, leverages artificial intelligence and machine learning algorithms to help healthcare institutions, laboratories and biopharmaceutical partners derive actionable insights from next-generation sequencing and medical imaging datasets.

The SOPHiA DDM™ platform supports a range of clinical applications, including oncology, hereditary diseases and rare genetic disorders.

Further Reading

• Five stocks we like better than SOPHiA GENETICS
• Microsoft Just Gave Investors 3 Dates They Can't Afford to Ignore
• NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
• The World Cup Is Coming—These 3 Stocks Could Cash In
• Spotify's "North Star" Outlook Was Music to Investors Ears

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].